Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pulmonary hypertension and systemic diseases.

Rossella Paolini1, Michela Armigliato, Sergio Zamboni

  • 1Division of Medicine, Rovigo General Hospital, Rovigo, Italy.

Current Drug Targets. Inflammation and Allergy
|December 9, 2004
PubMed
Summary

Systemic diseases like endocrine, HIV, and liver disorders can cause secondary pulmonary hypertension (sPH). This review explores the pathological role of these conditions in inducing sPH.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Gut Microbiota-Mast Cell Axis in Intestinal Homeostasis and Food Allergy Pathogenesis.

Biomolecules·2026
Same author

Targeting RNA polymerase I to boost natural killer cell anticancer activity in multiple myeloma.

Cell death & disease·2025
Same author

Incretin-Based Adjunct to Background Insulin Treatment for Managing Body Weight Excess in Type 1 Diabetes: An Expert Opinion Viewpoint From the Italian Association of Clinical Endocrinologists.

Diabetes/metabolism research and reviews·2025
Same author

Negative regulation of miRNA sorting into EVs is mediated by the capacity of RBP PCBP2 to impair the SYNCRIP-dependent miRNA loading.

eLife·2025
Same author

Beyond the "Master" Role in Allergy: Insights into Intestinal Mast Cell Plasticity and Gastrointestinal Diseases.

Biomedicines·2025
Same author

New Insight into Intestinal Mast Cells Revealed by Single-Cell RNA Sequencing.

International journal of molecular sciences·2024

Area of Science:

  • Cardiology
  • Pulmonology
  • Internal Medicine

Background:

  • Secondary pulmonary hypertension (sPH) is a serious complication linked to various systemic conditions.
  • Understanding the underlying systemic diseases is crucial for managing sPH.

Purpose of the Study:

  • To review the role of systemic diseases in the development of pulmonary hypertension (PH).
  • To provide a pathological classification of PH induced by systemic diseases.

Main Methods:

  • Literature review of studies on systemic diseases and secondary pulmonary hypertension.
  • Analysis of pathological mechanisms linking systemic disorders to PH.

Main Results:

  • Identified endocrine diseases, HIV infection, collagen diseases, liver disorders, and hematological disorders as key causes of sPH.
  • Detailed the pathological pathways through which these systemic diseases contribute to PH.

Conclusions:

  • Systemic diseases are significant contributors to the development of secondary pulmonary hypertension.
  • A pathological classification framework aids in understanding and potentially treating sPH based on its underlying systemic cause.

Related Experiment Videos